There is strong evidence supporting the role of the plasminogen activator system in head
and neck squamous cell carcinoma (HNSCC), particularly of its uPA (urokinase …

Myocardial infarction and ischemic stroke are the most frequent causes of death or disability
worldwide. Due to their ability to dissolve blood clots, the thrombolytics are frequently used …

Components of the plasminogen activation system including urokinase (uPA), its inhibitor
(PAI‐1) and its cell surface receptor (uPAR) have been implicated in a wide variety of …

Nucleic acid aptamer selection is a powerful strategy for the development of regulatory
agents for molecular intervention. Accordingly, aptamers have proven their diligence in the …

Многофункциональная система активатора плазминогена урокиназного типа (uPA-
система) включает сериновую протеиназу—uPA или урокиназу, ее рецептор—uPAR и …

Data accumulated over the latest two decades have established that the serine protease
urokinase-type plasminogen activator (uPA) is a potential therapeutic target in cancer. When …

Emphysema and liver cirrhosis can be caused by the Z mutation (Glu342Lys) in the serine
protease inhibitor α1-antitrypsin (α1AT), which is found in more than 4% of the Northern …

A marine fibrinolytic compound FGFC1 enhancing fibrinolysis was obtained involving
enzymatic kinetic parameters of a reciprocal activation system with a single chain urokinase …

The multifunctional urokinase-type plasminogen activator system (uPA-system) includes
serine proteinase—uPA or urokinase, its receptor (uPAR) and two inhibitors (PAI-1 and PAI …

We study oil-in-water microemulsions, in particular dispersions of n-decane droplets coated
with a monolayer of the surfactant C12E5 in a continuous phase of water. Upon addition of …